229 results on '"Lin, C-W"'
Search Results
2. 193P Engagement of sialylated glycans with Siglec receptors on suppressive myeloid cells inhibit anti-cancer immunity via CCL2
3. Two-Particle Correlations in Hadronic \(e^+e^-\) Collisions at Belle and Their Implication
4. 946P Non-examination of lymph nodes (LN) in early-stage non-small cell lung cancer (eNSCLC) is associated with wedge resections and underutilization of adjuvant (adv) chemotherapy
5. Modulation design of plasmonics for diagnostic and drug screening
6. College Students’ Choice Behavior of Electric Two-Wheeled Vehicle
7. Liver Resection with Radiofrequency Ablation for Colorectal Cancer Liver Metastasis
8. Using Radio Frequency Electrical Stimulation to Block External Urethral Sphincter Contraction and Improved Voiding Efficiency
9. CP01.01 Utilization of Cancer Immunotherapy Prior to Biomarker Test Results Among Patients with Advanced Non-Small Cell Lung Cancer in US Community Settings
10. Service Life Prediction of Seal in PEM Fuel Cells
11. Study on Posture Homeostasis – One Hour Pilot Experiment
12. DPPH free-radical scavenging activity, total phenolic contents and chemical composition analysis of forty-two kinds of essential oils
13. Correlation of in vivo and in vitro measurements of sun protection factor
14. What proportion of patients with chronic noncancer pain are prescribed an opioid medicine? Systematic review and meta‐regression of observational studies
15. Antibacterial activity of viable and heat‐killed probiotic strains against oral pathogens
16. Design of O-ring Driven Liquid-Filled Lens
17. The association between sarcopenia and osteoporotic vertebral compression refractures
18. Using non-continuous gold film as the seed layer for developing zinc oxide nanowire array
19. Scanning the Issue
20. Structure-activity and computer modeling studies on potent and selective CCK-A agonist tetrapeptides containing (N-Me)Asp or (N-Me)Asp-(N-Me)Phe
21. CCK heptapeptide analogs: Effect of conformational restrictions and standard modifications on selectivity and activity at CCK-A and CCK-B receptors
22. Boc-CCK-4 derivatives containing side chain ureas and amides as potent and selective CCK-A receptor agonists
23. Design of cholecystokinin analogs with high affinity and selectivity for brain CCK receptors
24. A prospective study of first-line Helicobacter pylori eradication therapy in treating localized extragastric mucosa-associated lymphoid tissue lymphoma
25. Anticonvulsants in the treatment of low back pain and lumbar radicular pain: a systematic review and meta-analysis
26. Periodontitis and dental scaling associated with pyogenic liver abscess: A population-based case-control study
27. Glecaprevir/pibrentasvir in patients with hepatitis C and prior treatment experience: an integrated phase II/III analysis
28. Properties of Ga–Zn–O Ultraviolet Phototransistors Using Radio-Frequency Magnetron Co-Sputtering Method
29. Begonia fulgurata (sect.Diploclinium,Begoniaceae), a new species from northern Thailand
30. Trissoplax tuberosa Castro & Ng, 2010 (Brachyura, Goneplacoidea), a new southern Taiwan record of the rare euryplacid crab
31. Dentoskeletal parameters related to visual perception of facial asymmetry in patients with skeletal class III malocclusion after orthognathic surgery
32. Core outcome measurement instruments for clinical trials in nonspecific low back pain
33. Crystal structure of IgG Fc with a homogeneous glycoform and Antibody-Dependent Cellular Cytotoxicity
34. Trial of Pregabalin for Acute and Chronic Sciatica
35. Abstract P2-01-10: Cumulative analysis of breast cancer sentinel lymph node identification rate by radioisotope: A 13-year experience
36. MAGELLAN-1, Part 2: glecaprevir and pibrentasvir for 12 or 16 weeks in patients with chronic hepatitis C virus genotype 1 or 4 and prior direct-acting antiviral treatment failure
37. ENDURANCE-3: safety and efficacy of glecaprevir/pibrentasvir compared to sofosbuvir plus daclatasvir in treatment-naïve HCV genotype 3-infected patients without cirrhosis
38. EXPEDITION-I: efficacy and safety of glecaprevir/pibrentasvir in adults with chronic hepatitis C virus genotype 1, 2, 4, 5 or 6 infection and compensated cirrhosis
39. Pharmacokinetics and safety of glecaprevir/pibrentasvir in adults with chronic genotype 1–6 hepatitis C virus infection and compensated cirrhosis: an integrated analysis
40. Influence of Al/Si Codiffusion on Current Gain Deterioration in AlGaN/GaN Single Heterojunction Bipolar Transistors
41. MgO/Cu2O Superlattices: Growth of Epitaxial Two-Dimensional Nanostructures
42. ISQUA16-2622EFFECTIVENESS OF IMPLEMENTING THE SMOKE-FREE HOSPITALS PROGRAM IN IMPROVING QUALITY
43. CagA and NFAT co-operatively participate in the lymphomagenesis of gastric MALT lymphoma
44. GaN Schottky diodes with single-crystal aluminum barriers grown by plasma-assisted molecular beam epitaxy
45. Broadband circularly polarized antenna with moon-shaped parasitic element
46. Endurance-3: A Phase 3, Randomized, Open-Label, Active-Controlled Study to Compare Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Co-Administered with Daclatasvir in Adults with HCV Genotype 3 Infection
47. High Svr Rates with ABT-493 + ABT-530 Co-Administered for 8 Weeks in Non-Cirrhotic Patients with HCV Genotype 3 Infection
48. 100% SVR4 with ABT-493 and ABT-530 with or without Ribavirin in Treatment-Naïve HCV Genotype 3-Infected Patients with Cirrhosis
49. High Efficacy and Favorable Safety of ABT-493 and ABT-530 Co-Administration for 12 Weeks in HCV Genotype 1-Infected Patients with Cirrhosis (Surveyor-I)
50. High SVR Rates with the Combination of ABT-493 + ABT-530 for 8 Weeks in Non-Cirrhotic Patients with HCV Genotype 1 or 2 Infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.